Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
doi:10.1016/j.arr.2022.101766
Personalized Treatment Planning: Once candidacy is confirmed, a customized treatment strategy is created
Galectin Therapeutics has started recruiting NASH patients with compensated cirrhosis for a Phase 2b/3 NAVIGATE clinical study (ClinicalTrials.gov NCT04365868) to begin evaluating the safety and efficacy of Belapectin (GR-MD-02), a complex carbohydrate that targets Galectin-3, a galactosidebinding lectin that plays an important role in inflammatory responses, 24 for the prevention of esophageal varices
However, ongoing IV treatments can be costly and time-consuming, making them less practical for long-term use
Apr 222026Inorganic chemistry CJC 1295 is an analog of growth hormone releasing hormone and a growth hormone secretagogue
Cost and Accessibility: The trial doesnt delve into the cost or practicality of long-term semaglutide use, which could impact its real-world application
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
